Latest Biogen Idec Stories
Biogen Idec ranks #1, 85% of the Global 100 firms link executive pay to sustainability targets. DAVOS, Switzerland, Jan.
-- First biosimilar from Samsung Bioepis to advance to EMA regulatory review -- INCHEON, South Korea, Jan.
CARLSBAD, Calif., Jan. 14, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
Accelerates RG-101 for HCV with Dual-Track Clinical Development Strategy; Top-Line, Single Dose, 4 mg/kg Results as Well as 2mg/kg Extended Follow Up Results from Ongoing Study to be Reported in Early
LONDON, Jan. 7, 2015 /PRNewswire/ -- About Psoriasis and Its TypesPsoriasis is a common immune-mediated disease of the skin.
ISIS-DMPK Rx Extends the Targeting of Antisense Drugs to Include Muscle Tissue CARLSBAD, Calif., Dec. 16, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
Mediaplanet announces distribution of its first cross-platform edition of Neurological Conditions, educating Canadians on the socio-economic
CARY, N.C., Dec.
- Large; stout; burly.